Skip to main content

Table 2 Odds-ratio (OR) of clinical parameters for worsening of asthma control

From: Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong Kong

 

OR

95% C.I

p-value

aOR

95% C.I

p-value

≥ 3 points decrease in ACT score

4.174

2.116–8.234

 < 0.001*

3.105

1.385–6.959

0.006*

Escalation of asthma maintenance therapy by at least 1 GINA step

3.798

1.349–10.694

0.012*

4.733

1.151–19.467

0.031*

Asthma uncontrolled

2.774

1.214–6.338

0.016*

5.509

1.061–28.600

0.042*

Asthma from controlled to uncontrolled

8.209

3.018–22.233

 < 0.001*

7.532

2.268–25.013

 < 0.001*

Medical attendance for asthmatic exacerbation

1.083

0.471–2.492

0.851

Oral corticosteroid prescribed for exacerbation

1.298

0.466–3.618

0.618

  1. Adjusted for age, gender, smoking status, baseline FEV1 (% predicted), COVID-19 vaccination status, ACT score at prior visit 12 months before and GINA step of medication at baseline
  2. OR odds ratio, aOR adjusted odds ratio, GINA global Initiative for asthma
  3. *Statistically significant